BTRC and cancer: MiR-135b expression enhances cancer cell invasive and migratory abilities in vitro and promotes cancer metastasis in vivo by targeting multiple key components on the Hippo pathway, including LATS2, BTRCP and NDR2, as well as LZTS1 [41].